New Zealand's science-led response to the SARS-CoV-2 pandemic.
Nat Immunol
; 22(3): 262-263, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33627881
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Public Policy
/
Communicable Disease Control
/
Public Health
/
COVID-19
Type of study:
Prognostic_studies
/
Screening_studies
Aspects:
Determinantes_sociais_saude
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Nat Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
New Zealand
Country of publication:
United States